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Abstract
Anti-severe acute respiratory syndrome coronavirus 2 (anti-SARS-CoV-2) nucleoprotein (NP) antibodies were isolated 
from pig sera using human SARS-CoV-2 NP-immobilized magnetic beads. The binding properties of the isolated antibodies 
against SARS-CoV-2 NP were tested via flow cytometry using SARS-CoV-2 NP-immobilized magnetic beads. A competitive 
immunoassay was developed for detecting SARS-CoV-2 NP as well as SARS-CoV-2 in the culture fluid using magnetic beads 
with immobilized anti-SARS-CoV-2 NP antibodies. Selectivity tests were carried out during the competitive immunoassay 
for SARS-CoV, MERS-CoV, and CoV strain 229E in the culture fluid.
Keywords Competitive assay · SARS-CoV-2 · Culture fluid · Anti-SARS-CoV-2 nucleoprotein antibody · Nucleoprotein 
(NP)
1 Introduction
Severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) is a beta-corona virus, and four protein types (spike 
proteins, membrane proteins, envelop proteins, and nucle-
oproteins (NPs)) have been used for detecting this virus. 
Among these, NPs have been most frequently used for devel-
oping vaccines and the SARS-CoV-2 antigen test for in vitro 
diagnosis of coronavirus disease 2019 (COVID-19) [1, 2]. 
Recently, the antibodies against human SARS-CoV-2 nucle-
oprotein (NP) from pig sera were used for detecting human 
SARS-CoV-2 in the culture fluid. This detection of human 
SARS-CoV-2 was possible because (1) a certain portion of 
virus particles was broken to release NP into the culture fluid 
[3] and (2) the NPs of humans and pigs presented highly 
homologous amino acid sequences (> 40%) during BLAST 
analysis. In a previous report, anti-SARS-CoV-2 NP anti-
bodies were used to detect SARS-CoV-2 and other corona-
viruses such as MERS-CoV and CoV strain 229E using the 
surface plasmon resonance biosensor [4].
Sandwich-type immunoassays have been used to detect 
antigens in samples using immobilized antibodies. In gen-
eral, the response from the binding of antigens to the immo-
bilized antibodies was generated in proportion to the antigen 
concentration in the samples [5–7]. In the case of competi-
tive immunoassays, antigens in the sample compete for their 
binding sites with a fixed concentration of antigen-like sign-
aling molecules. The signal from the indirect immunoas-
says usually decreased as the antigen concentration in the 
samples increased because the antigen-like signaling mol-
ecules were released from the immobilized antibodies. Such 
indirect immunoassays have been used to evaluate whether 
a certain target molecule was included in the sample, such 
as narcotics [8, 9] and insecticides [10–12].
In the present study, we presented a competitive immu-
noassay to detect SARS-CoV-2 using isolated anti-SARS-
CoV-2 NP antibodies from pig sera, which exhibited a bind-
ing affinity to SARS-CoV-2 NP via immunoassays with 
immobilized antibodies and flow cytometry with magnetic 
beads of immobilized SARS-CoV-2 NP. The competitive 
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immunoassay was configured by mixing magnetic beads 
with immobilized SARS-CoV-2 NPs and known concen-
trations of the isolated antibodies. The competitive assay 
overcame the Hook effect at high concentrations of SARS-
CoV-2 and the narrow dynamic detection range of the stand-
ard rapid test for the SARS-CoV-2 Ag test. Eventually, a 
selectivity test was carried out for the competitive immuno-
assay for SARS-CoV, MERS-CoV, and CoV strain 229E in 
the culture fluid.
2  Results and Discussion
2.1  Isolation of Anti‑SARS‑CoV‑2 NP Antibody 
from Pig Sera
Anti-SARS-CoV-2 NP antibodies were isolated from pig 
sera using human SARS-CoV-2 NP-immobilized magnetic 
beads. As previously reported, SARS-CoV-2 NPs were 
immobilized on the magnetic beads via covalent bond-
ing between the amino groups of SARS-CoV-2 NP and 
tosyl group present on the magnetic beads. As illustrated 
in Fig. 1(a), the isolation was carried out through the fol-
lowing steps: (1) incubation of pig sera for the binding of 
anti-SARS-CoV-2 NP antibodies to the magnetic beads, 
(2) acid dissociation of the bound proteins including 
anti-SARS-CoV-2 NP antibodies on the magnetic beads, 
and (3) protein-A purification of antibody (IgG) fraction 
among the dissociated proteins.
The isolated fraction was analyzed using SDS-PAGE, 
as illustrated in Fig. 1(b). To assess the antibody fraction 
after protein-A purification, the protein band correspond-
ing to IgG (150 kDa) was observed without the treatment 
with the reducing agent dithiothreitol (DTT). After treat-
ment with DTT for the reduction of disulfide bonds in IgG, 
the protein bands of the light chain (~ 25 kDa) and heavy 
chain (~ 50 kDa) of IgG were observed. These results indi-
cated that the isolated proteins from pig sera corresponded 
to the IgG fraction. The isolation yield was estimated to be 
2.91% ± 0.7% because 156 μg protein was obtained from 
1 mL of pig sera before protein-A purification (n = 5). 
Eventually, the yield of antibody isolation was estimated 
to be 0.24% ± 0.05% because 12.3 μg of antibodies (IgG) 
was isolated from 1 mL of pig sera after protein-A puri-
fication (n = 5).
Fig. 1  Isolation of anti-SARS-
CoV-2 NP antibodies from pig 
sera. a Isolation procedure of 
anti-SARS-CoV-2 NP antibod-
ies. b SDS-PAGE analysis of 
isolated anti-SARS-CoV-2 NP 




2.2  Binding Properties of Anti‑SARS‑CoV‑2 NP 
Antibody
As previously reported, the binding properties of anti-SARS-
CoV-2 NP antibodies were tested using immobilized SARS-
CoV-2 NP proteins on a microplate and on magnetic beads. 
Initially, SARS-CoV-2 NP protein was immobilized on the 
microplate through hydrophilic and hydrophobic interac-
tions, and then the isolated anti-SARS-CoV-2 NP antibod-
ies were added to the microplate. As illustrated in Fig. 2(a), 
the amount of bound antibodies to the microplate was esti-
mated using anti-pig IgG antibodies labeled with HRP and 
a chromogenic reaction with 3,3′,5,5′-tetramethylbenzidine 
(TMB). Eventually, the OD value was measured at 450 nm 
after quenching with sulfuric acid. As a negative control, a 
bovine serum albumin (BSA)-blocked microplate was used. 
As illustrated in Fig. 2(b), the OD value was increased in the 
antibody concentration range of 0.14–10.0 μg/mL (n = 3). 
In the negative control group, the OD value remained at 
the baseline level (n = 3). These results indicated that the 
isolated anti-SARS-CoV-2 NP antibodies from pig sera 
could bind specifically to the immobilized SARS-CoV-2 
NP proteins.
The quantitative binding of anti-SARS-CoV-2 NP anti-
bodies was analyzed via flow cytometry with SARS-CoV-2 
NP-immobilized magnetic beads. As depicted in Fig. 3(a), 
the assay was carried out by mixing SARS-CoV-2 NP 
immobilized magnetic beads and samples at different con-
centrations of anti-SARS-CoV-2 NP antibodies. For the 
Fig. 2  Binding properties of the isolated anti-SARS-CoV-2 NP anti-
bodies from pig sera. a Configuration of immunoassay. b Immuno-
assay results with the isolated SARS-CoV-2 NP immobilized on a 
microplate
Fig. 3  Quantitative binding of anti-SARS-CoV-2 NP antibodies using 
flow cytometry with the isolated anti-SARS-CoV-2 NP on magnetic 
beads. a Configuration of the quantitative binding test. b Results 
of flow cytometry with anti-SARS-CoV-2 NP antibodies bound to 
SARS-CoV-2 NP on the magnetic beads. c Standard curve for quanti-




quantitative analysis of the bound anti-SARS-CoV-2 NP 
antibodies, the secondary antibody was reacted against pig-
IgG labeled with fluorescein (λex = 488 nm, λem = 508 nm). 
Using the flow cytometry of magnetic beads, the fluores-
cence intensity from these beads was measured for differ-
ent concentrations of isolated antibodies, as illustrated in 
Fig. 3(b). From the dose–response curve of flow cytometry 
(Fig. 3(c)), the anti-SARS-CoV-2 NP antibodies could be 
quantified at a concentration range of 0.03–22.2 μg/mL 
(n = 3). Considering the four parameter logistic equation 
[13], the binding constant  (KD) of the isolated antibody 
against the immobilized SARS-CoV-2 NP on the magnetic 
beads was estimated to be 1.15 nM (n = 3).
2.3  Competitive Immunoassay of SARS‑CoV‑2
As previously reported, the isolated anti-SARS-CoV-2 NP 
antibodies from pig sera could be used to detect SARS-
CoV-2 NP as well as SARS-CoV-2 in the culture fluid. In 
the present study, an assay was configured based on the 
competitive immunoassay for the quantitative analysis of 
SARS-CoV-2 NP as well as SARS-CoV-2 using magnetic 
beads with immobilized SARS-CoV-2 NP. As illustrated 
in Fig. 4(a), the magnetic beads and a known concentra-
tion of anti-SARS-CoV-2 NP antibodies were mixed with 
the samples. When the sample had SARS-CoV-2 NP (or 
SARS-CoV-2), the isolated antibodies were bound to both 
magnetic beads and SARS-CoV-2 NP (or SARS-CoV-2). 
Eventually, secondary antibodies against pig-IgG labeled 
with fluorescein were used to quantify the bound antibod-
ies on the magnetic beads. In the negative samples lack-
ing SARS-CoV-2 NP (or SARS-CoV-2), all the isolated 
antibodies were bound to the magnetic beads. Therefore, 
when the secondary antibodies against pig-IgG labeled with 
fluorescein were treated, a remarkably higher fluorescence 
signal was observed from the magnetic beads. Therefore, 
the fluorescence signal decreased with an increase in the 
SARS-CoV-2 NP (or SARS-CoV-2) in the sample, and the 
positiveness of the sample could be evaluated by considering 
the difference between signals of the positive and negative 
samples.
First, SARS-CoV-2 NP was quantified in samples using 
a competitive assay. As illustrated in Fig. 4(b), PBS with-
out SARS-CoV-2 NP was used as a negative control. When 
samples with SARS-CoV-2 NP were applied to the competi-
tive assay, the fluorescence signal gradually decreased in the 
concentration range of 0.12–10.0 μg/mL and the signal was 
maintained at a baseline level above the concentration of 
1 µg/mL (Fig. 4(c)). These results indicate that the com-
petitive assay could be used for the quantitative analysis of 
SARS-CoV-2 NP.
Second, SARS-CoV-2 in the culture fluid was evalu-
ated via a competitive assay. The quantification of 
SARS-CoV-2 was carried out using a rapid test for SARS-
CoV-2 from SD Biosensors (Seoul, Korea) [14]. As illus-
trated in Fig. 5(a), the signal band was observed for the 
samples with diluted SARS-CoV-2 culture fluid, and the 
control bands indicated the validity of the test. According 
to the manufacturer’s manual [14], the cutoff value for 
determining the positivity of COVID-19 was established 
to be the dilution factor of 925, corresponding to a culture 
fluid fraction of 0.11%. As illustrated in Fig. 5(b), PBS 
without diluted SARS-CoV-2 culture fluid was used as a 
negative control for both the rapid test and the competitive 
assay. In the case of the rapid test, a linear detection range 
was observed in the dilution fraction range of 0.15%–1%. 
For the higher dilution fraction, the signal was observed to 
decrease, which indicated the Hook effect of the immuno-
assay. For the lower dilution fraction, the signal remained 
at the baseline level. When the diluted samples of SARS-
CoV-2 culture fluid were applied to the competitive assay, 
the fluorescence signal gradually decreased the dilution 
fraction of 0.078%–5%, and the quantitative analysis was 
determined to be possible in the whole range of used dilu-
tion fractions (n = 6). These results indicated that (1) the 
competitive assay had a considerably wider detection 
range than that observed in the conventional rapid test 
and (2) the competitive assay could be used even for the 
dilution fraction range where the Hook effect occurred (in 
the range of high dilution fraction) and the detection limit 
was attained (in the range of low dilution fraction).
Third, the selectivity of the competitive assay was 
tested against SARS-CoV-2 and other types of coronavi-
ruses of SARS-CoV, MERS-CoV, and CoV strain 229E. 
The culture fluid of CoV strain 229E was used as a nega-
tive control. To compare the assay signals, normalized 
fluorescence intensity was used in the dilution fraction 
range of 0.078%–5%. As shown in Fig. 5(c), the coronavi-
ruses SARS-CoV-2, SARS-CoV, and MERS-CoV revealed 
quantitative response according to the dilution fraction of 
each culture fluid. Such response indicated that the iso-
lated anti-SARS-CoV-2 NP antibodies had a binding affin-
ity against NP proteins from the corresponding viruses. 
In particular, the signals of the competitive assay from 
SARS-CoV-2 and SARS-CoV were quite similar because 
the homology of amino acid sequences in both NPs was 
estimated to be more than 90% (Table 1) from BLAST 
analysis, whereas the homology in MERS-CoV and CoV 
strain 229E was 48% (Table 2) and 29% (Table 3), respec-
tively. These results indicated that a competitive assay 
based on magnetic beads with immobilized NPs could 
be used for the quantitative analysis of SARS-CoV-2 and 
other types of coronaviruses of SARS-CoV, MERS-CoV, 




Anti-SARS-CoV-2 NP antibodies were isolated from pig 
sera using SARS-CoV-2 NP-immobilized magnetic beads, 
via the three steps discussed in the Results and Discussion 
section. Finally, the yield of isolated antibody was esti-
mated to be 0.24% ± 0.05% because 12.3 μg of antibodies 
(IgG) was isolated from 1 mL of pig sera after protein-
A purification (n = 5). From the dose–response curve of 
flow cytometry, the quantification of anti-SARS-CoV-2 
Fig. 4  Competitive immunoas-
say using the isolated anti-
SARS-CoV-2 NP antibodies on 
magnetic beads. a Configuration 
of competitive immunoassay. b 
Results of flow cytometry for 
quantitative analysis of SARS-
CoV-2 NP using competitive 
immunoassay. c Standard curve 
for quantitative analysis of 




NP antibodies was possible at 0.03–22.2 μg/mL (n = 3), 
and the binding constant  (KD) of the isolated antibody 
against SARS-CoV-2 NP on the magnetic beads was esti-
mated to be 1.15 nM (n = 3). A configuration based on the 
competitive immunoassay was developed for the quantita-
tive analysis of SARS-CoV-2 NP as well as SARS-CoV-2 
using magnetic beads with immobilized SARS-CoV-2 NP. 
When diluted samples of SARS-CoV-2 culture fluid were 
applied to the competitive assay, the fluorescence signal 
gradually decreased the dilution fraction of 0.078%–5%, 
and the quantitative analysis was carried out for the entire 
range of used dilution fractions. These results indicated 
that (1) the competitive assay had a far wider detec-
tion range than the conventional rapid test and (2) the 
Fig. 5  Competitive immunoas-
say of SARS-CoV-2. a Results 
of a rapid test for the diagnosis 
of SARS-CoV-2 antigen test 
using diluted culture fluid with 
SARS-CoV-2. b Comparison of 
the standard curve for quantita-
tive analysis of SARS-CoV-2 
using rapid test and competitive 
immunoassay. c Selectivity test 
for competitive immunoassay of 




competitive assay could be used even for the dilution 
fraction range where the Hook effect occurred (in the 
range of high dilution fraction) and the detection limit 
was attained (in the range of low dilution fraction). Using 
the selectivity test for SARS-CoV-2 and other kinds of 
coronaviruses such as SARS-CoV, MERS-CoV and CoV 
strain 229E, a competitive assay based on the magnetic 
beads with immobilized SARS-CoV-2 NP was used to 
quantify these viruses.
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4  Materials and Methods
4.1  Materials
Anti-pig IgG labeled with horseradish peroxidase 
(ab102135) or fluorescein (ab9611) was purchased from 
Abcam (Cambridge, UK). The tosyl-activated magnetic 
beads (diameter of 2.8 µm, 14203) were purchased from 
Invitrogen Co. (Carlsbad, CA, USA). BSA (A2153) and 
other chemicals were purchased from Sigma-Aldrich 
Korea (Seoul, Korea). The bicinchoninic acid (BCA) assay 
kit (23227), pig sera (porcine sera, 26250084), and TMB 
reagent with  H2O2 solution (34021) were purchased from 
Thermo Fisher Scientific (Waltham, MA, USA). Maxib-
inding microplates (32296) were purchased from SPL Life 
Science (Pocheon, Korea). Culture fluids of SARS-CoV-2 
(0810587CFHI), MERS-CoV (0810575CFHI), CoV strain 
229E (0810229CFHI), and SARS-CoV (NATSARS-ST) 
were purchased from Zeptometrix (Buffalo, NY, USA). The 
His-tagged SARS-CoV-2 nucleoprotein (SARS-CoV-2 NP) 
was supplied by Genbody Inc. (Cheonan, Korea) and Opto-
lane Inc. (Seongnam, Korea).
4.2  Purification of Anti‑SARS‑CoV‑2 Antibodies
The antibodies were isolated from pig sera using the fol-
lowing procedure. Initially, the pig sera (1 mL) were added 
to magnetic beads coated with SARS-CoV-2 NP (10 mg). 
Thereafter, the reaction tube was mixed continuously with a 
wheel-rotating mixer (RT-10, Daehan Scientific Co, Wonju, 
Korea) for 1 h. The beads were prepared according to the 
manufacturer’s instructions. Next, the proteins bound to the 
beads were dissociated by treatment with 1 mL of 0.1 M 
glycine–HCl buffer (pH 2.7) for 10 s. Furthermore, Tris–HCl 
buffer (1 M, pH 10.5, 50 μL) was added for neutralization. 
The SARS-CoV-2 NP antibodies were eventually purified 
using a protein-A column without unwanted proteins. The 
product was finally concentrated with Amicon centrifugal 
filtration (molecular weight cutoff: 3 kDa). The yield of anti-
bodies was determined as the amount of protein isolated 
from a unit volume (1 mL) of pig sera. The concentration of 
protein was estimated using a BCA assay kit from Thermo 
Fisher Scientific (Waltham, MA, USA).
4.3  The Binding Affinity Analysis 
of Anti‑SARS‑CoV‑2 Antibodies
Immunoassays using microplates (Fig. 2) and flow cytom-
etry (Fig. 3) were performed to analyze the binding affinity 
of the isolated antibodies. For the microplate assay, the pro-
teins (SARS-CoV-2 NP) were immobilized on a Maxibind-
ing plate for 2 h at 100 μg/mL. Thereafter, each well was 
blocked with BSA (5 mg/mL, 1 h). The SARS-CoV-2 anti-
bodies were added to each well at various concentrations, 
followed by a secondary antibody reaction (100 ng/mL, 1 h 
for both antibodies). After washing once with PBST and 
twice with PBS, the colorimetric reaction was performed 
using the TMB reagent with  H2O2 (1:1 retio, 100 μL) for 
3 min. The optical density was measured at a wavelength 
of 450 nm after quenching with 2 M sulfuric acid (100 μL) 
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using a microplate reader (Versamax Microplate reader) 
from Molecular Devices Co. (San Jose, CA, USA).
For the assay based on flow cytometry, 0.1 mg of the 
magnetic beads immobilized with SARS-CoV-2 NP was 
utilized. Anti-SARS-CoV-2 NP antibodies were incubated 
for 1 h at various concentrations, followed by the reaction of 
anti-pig(FITC) antibody solution (5 μg/mL, 1 h). After the 
aforementioned washing step, the fluorescence signals were 
obtained using FACSCalibur (BD, NJ, USA).
4.4  Competitive Assay of Anti‑SARS‑CoV‑2 
Antibodies
The magnetic beads (0.1 mg) were aliquoted into each vial. 
Then various concentrations of SARS-CoV-NP (100 μL) and 
fixed concentration of anti-SARS-CoV-2 antibody (12.5 μg/
mL, 100 μL) were added simultaneously. After 1 h of wash-
ing, anti-pig(FITC) antibody solution (12.5 μg/mL, 100 
μL) was incubated for 1 h. The fluorescence signals were 
obtained using FACSCalibur (BD, NJ, USA).
4.5  Standard Curve Fitting
The results were fitted with the four parameter logistic equa-
tion [15, 16] as described below:
where a and d are the maximum and minimum signals 
(a.u.), respectively; c is the concentration of SARS-CoV-2 
NP (pM), and b is the Hill’s slope of the curve.
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